- Clinical drug investigation
-
影响因子:
1.915
-
I S S N:
1173-2563
-
出 版 社:
Adis International
-
出 版 地:
Mairangi Bay, Auckland, N.Z., Philadelphia
-
出版国家:
New Zealand
-
刊 期:
月刊
-
创刊时间:
1995
-
语 种:
英文
-
审稿周期:
较慢,6-12周
-
中科院分区:
4
-
投稿命中率:
较易
-
国外数据库收录:
IM
-
中国收录文章数:
23
-
5年影响因子:
1.639
-
研究领域:
临床试验专题、药物评价、药物治疗、药物研究、研究性新药申请、药物制剂
-
官方链接:
http://link.springer.com/journal/40261
-
投稿须知:
http://link.springer.com/journal/40261
期刊介绍:
Clinical Drug Investigation gives you rapid access to the best designed, peer reviewed clinical and pharmacoeconomic studies worldwide, allowing you to keep up to date with the latest original research in this exciting area. The Journal's aim is rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. This includes clinical trials, outcomes research, clinical pharmacoeconomic studies, pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs, clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice and, in some instances, pharmacodynamic or pharmacokinetic studies in healthy volunteers, but in which some established or purported implications for clinical prescribing are discussed. In addition, short communications and case study reports that meet these criteria are also encouraged, as are letters to the editor.